BAUSCH + LOMB CORP (BLCO) Stock Fundamental Analysis

NYSE:BLCO • CA0717051076

18.44 USD
+0.45 (+2.5%)
At close: Feb 24, 2026
18.54 USD
+0.1 (+0.54%)
After Hours: 2/24/2026, 8:10:57 PM
Fundamental Rating

3

Overall BLCO gets a fundamental rating of 3 out of 10. We evaluated BLCO against 185 industry peers in the Health Care Equipment & Supplies industry. BLCO has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLCO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year BLCO was profitable.
  • In the past year BLCO had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
  • Of the past 5 years BLCO 4 years had a positive operating cash flow.
BLCO Yearly Net Income VS EBIT VS OCF VS FCFBLCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • With a decent Return On Assets value of -2.57%, BLCO is doing good in the industry, outperforming 69.19% of the companies in the same industry.
  • BLCO's Return On Equity of -5.58% is fine compared to the rest of the industry. BLCO outperforms 69.73% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.23%, BLCO is in the better half of the industry, outperforming 65.95% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLCO is significantly below the industry average of 8.75%.
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROIC 1.23%
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
BLCO Yearly ROA, ROE, ROICBLCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 -4

1.3 Margins

  • The Operating Margin of BLCO (3.69%) is better than 67.03% of its industry peers.
  • In the last couple of years the Operating Margin of BLCO has declined.
  • BLCO's Gross Margin of 59.81% is fine compared to the rest of the industry. BLCO outperforms 61.08% of its industry peers.
  • In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
Industry RankSector Rank
OM 3.69%
PM (TTM) N/A
GM 59.81%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
BLCO Yearly Profit, Operating, Gross MarginsBLCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLCO is destroying value.
  • Compared to 1 year ago, BLCO has more shares outstanding
  • BLCO has more shares outstanding than it did 5 years ago.
  • BLCO has a worse debt/assets ratio than last year.
BLCO Yearly Shares OutstandingBLCO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BLCO Yearly Total Debt VS Total AssetsBLCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • BLCO has an Altman-Z score of 0.91. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
  • BLCO has a Altman-Z score of 0.91. This is comparable to the rest of the industry: BLCO outperforms 50.27% of its industry peers.
  • BLCO has a Debt/Equity ratio of 0.78. This is a neutral value indicating BLCO is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.78, BLCO is not doing good in the industry: 69.73% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 0.91
ROIC/WACC0.12
WACC9.85%
BLCO Yearly LT Debt VS Equity VS FCFBLCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that BLCO should not have too much problems paying its short term obligations.
  • BLCO has a Current ratio of 1.55. This is in the lower half of the industry: BLCO underperforms 73.51% of its industry peers.
  • A Quick Ratio of 1.04 indicates that BLCO should not have too much problems paying its short term obligations.
  • BLCO's Quick ratio of 1.04 is on the low side compared to the rest of the industry. BLCO is outperformed by 75.68% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.04
BLCO Yearly Current Assets VS Current LiabilitesBLCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

  • BLCO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.35%.
  • BLCO shows a small growth in Revenue. In the last year, the Revenue has grown by 6.47%.
  • BLCO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.38% yearly.
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%

3.2 Future

  • Based on estimates for the next years, BLCO will show a very strong growth in Earnings Per Share. The EPS will grow by 32.47% on average per year.
  • Based on estimates for the next years, BLCO will show a small growth in Revenue. The Revenue will grow by 3.83% on average per year.
EPS Next Y60.98%
EPS Next 2Y47.19%
EPS Next 3Y40.75%
EPS Next 5Y32.47%
Revenue Next Year5.85%
Revenue Next 2Y5.67%
Revenue Next 3Y5%
Revenue Next 5Y3.83%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLCO Yearly Revenue VS EstimatesBLCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO Yearly EPS VS EstimatesBLCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 36.88, the valuation of BLCO can be described as expensive.
  • BLCO's Price/Earnings ratio is a bit cheaper when compared to the industry. BLCO is cheaper than 71.89% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.98. BLCO is valued slightly more expensive when compared to this.
  • The Price/Forward Earnings ratio is 22.91, which indicates a rather expensive current valuation of BLCO.
  • BLCO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BLCO is cheaper than 76.76% of the companies in the same industry.
  • BLCO is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.01, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 36.88
Fwd PE 22.91
BLCO Price Earnings VS Forward Price EarningsBLCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • BLCO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BLCO is cheaper than 76.76% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.18
BLCO Per share dataBLCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • BLCO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BLCO's earnings are expected to grow with 40.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y47.19%
EPS Next 3Y40.75%

0

5. Dividend

5.1 Amount

  • BLCO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BAUSCH + LOMB CORP

NYSE:BLCO (2/24/2026, 8:10:57 PM)

After market: 18.54 +0.1 (+0.54%)

18.44

+0.45 (+2.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-18
Earnings (Next)N/A
Inst Owners11.05%
Inst Owner Change3.17%
Ins Owners0.45%
Ins Owner Change4.16%
Market Cap6.53B
Revenue(TTM)5.10B
Net Income(TTM)-360.00M
Analysts72.63
Price Target17.68 (-4.12%)
Short Float %8.7%
Short Ratio10.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.14%
Min EPS beat(2)-10.76%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)-90.21%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)5
Avg EPS beat(8)-43.92%
EPS beat(12)8
Avg EPS beat(12)-25.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.28%
Revenue beat(8)2
Avg Revenue beat(8)-0.31%
Revenue beat(12)5
Avg Revenue beat(12)0.68%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.97%
PT rev (3m)4.32%
EPS NQ rev (1m)3.86%
EPS NQ rev (3m)-1.08%
EPS NY rev (1m)0.21%
EPS NY rev (3m)0.88%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 36.88
Fwd PE 22.91
P/S 1.28
P/FCF N/A
P/OCF 23.09
P/B 1.01
P/tB N/A
EV/EBITDA 18.18
EPS(TTM)0.5
EY2.71%
EPS(NY)0.8
Fwd EY4.37%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)0.8
OCFY4.33%
SpS14.4
BVpS18.2
TBVpS-4.49
PEG (NY)0.6
PEG (5Y)N/A
Graham Number14.31
Profitability
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROCE 1.55%
ROIC 1.23%
ROICexc 1.27%
ROICexgc 4.04%
OM 3.69%
PM (TTM) N/A
GM 59.81%
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
ROICexc(3y)1.38%
ROICexc(5y)1.81%
ROICexgc(3y)4.6%
ROICexgc(5y)6.09%
ROCE(3y)1.7%
ROCE(5y)2.22%
ROICexgc growth 3Y-15.27%
ROICexgc growth 5Y-11.42%
ROICexc growth 3Y-14.77%
ROICexc growth 5Y-9.61%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 8.28
Cap/Depr 82.9%
Cap/Sales 6.84%
Interest Coverage 0.49
Cash Conversion 46.47%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.04
Altman-Z 0.91
F-Score3
WACC9.85%
ROIC/WACC0.12
Cap/Depr(3y)65.67%
Cap/Depr(5y)57.94%
Cap/Sales(3y)5.76%
Cap/Sales(5y)5.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
EPS Next Y60.98%
EPS Next 2Y47.19%
EPS Next 3Y40.75%
EPS Next 5Y32.47%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%
Revenue Next Year5.85%
Revenue Next 2Y5.67%
Revenue Next 3Y5%
Revenue Next 5Y3.83%
EBIT growth 1Y-7.39%
EBIT growth 3Y-8.57%
EBIT growth 5Y-6.91%
EBIT Next Year65.28%
EBIT Next 3Y28.24%
EBIT Next 5Y16.65%
FCF growth 1Y-11.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.98%
OCF growth 3Y-6.39%
OCF growth 5Y-11.52%

BAUSCH + LOMB CORP / BLCO FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLCO.


What is the valuation status of BAUSCH + LOMB CORP (BLCO) stock?

ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Fairly Valued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.


What is the financial health of BAUSCH + LOMB CORP (BLCO) stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.